Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership – a qualitative study of policy actors’ views
Abstract Background The Regional Economic Partnership Agreement (RCEP) is a mega regional trade agreement signed by fifteen countries on 15 November 2020 after 8 years of negotiation. Signatories include the ten members of the Association of South East Asian Nations (ASEAN) plus China, New Zealand,...
Main Author: | Belinda Townsend |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Globalization and Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12992-021-00721-4 |
Similar Items
-
Mega-Regionalism in Trade from a Sectoral Perspective. The Case of the Automotive Industry in the Regional Comprehensive Economic Partnership
by: Sebastian Bobowski, et al.
Published: (2023-05-01) -
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
by: Deborah Gleeson, et al.
Published: (2019-11-01) -
Trends in Global and Regional Integration by means of Trade
by: Iulia Monica Oehler-Șincai
Published: (2014-04-01) -
Regional trade agreements: development and barriers
by: Ekaterina Lisitsa
Published: (2018-04-01) -
TPP versus RCEP: Control of Membership and Agenda Setting
by: Shintaro Hamanaka
Published: (2014-06-01)